Moreover, our previous research reported that GC, a specific CD40 inhibitor, could exhibit significant protective effect of myocardial ischemia and reperfusion injury via suppressing the CD40/NF-κB signal pathway. The gene discussed is CD40; the disease is myocardial ischemia.